玻璃体切除术结束时玻璃体腔注射曲安奈德对增殖性糖尿病视网膜病变相关玻璃体出血的效应
这项在日本7个中心开展的前瞻性随机研究纳入增殖性糖尿病视网膜病变合并玻璃体出血行玻璃体切除术的患者,比较术终联合或不联合玻璃体腔注射曲安奈德(IVTA)的效果。结果显示IVTA联合玻璃体切除及白内障手术有助于抑制术后炎症,但IVTA减轻糖尿病黄斑水肿的作用可能仅限于术后早期。
要点
- IVTA联合玻璃体切除及白内障手术有助于抑制增殖性糖尿病视网膜病变玻璃体出血患者的术后炎症。
- 术后3天(P=0.033)、1周(P=0.019)和1个月(P=0.037)前房闪辉强度VIT组显著高于IVTA+VIT组。
- IVTA减轻糖尿病黄斑水肿的作用可能仅限于术后早期。
核心结论
- IVTA联合玻璃体切除及白内障手术有助于抑制增殖性糖尿病视网膜病变玻璃体出血患者的术后炎症。
- IVTA减轻糖尿病黄斑水肿的作用可能仅限于术后早期。
研究设计与样本
- 前瞻性、多中心、随机研究,在日本7个中心开展,纳入诊断为增殖性糖尿病视网膜病变后玻璃体出血的患者。
- 患者行玻璃体切除术,术终联合(IVTA+VIT组)或不联合(VIT组)玻璃体腔注射曲安奈德。
- 完成6个月随访的患者VIT组40例、IVTA+VIT组41例。
主要发现
- 前房闪辉强度VIT组显著高于IVTA+VIT组:3天(P=0.033)、1周(P=0.019)、1个月(P=0.037)。
- 观察期内两组中央视网膜厚度、最佳矫正视力和眼压均无显著差异。
- 术后3天中央视网膜厚度>350 µm的黄斑水肿病例中,1个月时中央视网膜厚度IVTA+VIT组显著低于VIT组(P=0.041)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND/AIMS: To investigate whether intravitreal injection of triamcinolone acetonide (IVTA) combined with vitrectomy prevents postoperative inflammation in patients with vitreous haemorrhage (VH) due to proliferative diabetic retinopathy (PDR). METHODS: This prospective, multicentre, randomised study conducted at seven sites in Japan enrolled patients diagnosed as having VH following PDR. Patients underwent vitrectomy with (IVTA+VIT group) or without (VIT group) IVTA at the end of the surgery. Anterior flare intensity (AFI), central retinal thickness (CRT), best-corrected visual acuity (BCVA) and intraocular pressure (IOP) were measured before and at 3 days, 1 week, 1, 3 and 6 months after surgery and compared. RESULTS: Number of patients who completed 6 months of follow-up was 40 and 41 in VIT group and IVTA+VIT group, respectively. AFI was significantly higher in the VIT group than in the IVTA+VIT group at 3 days (P=0.033), 1 week (P=0.019) and 1 month (P=0.037). There were no significant differences in CRT, BCVA and IOP between the groups through the observational periods. In the cases with macular oedema >350 µm of CRT at 3 days, CRT was significantly lower in the IVTA+VIT group than in the VIT group at 1 month (P=0.041). CONCLUSIONS: IVTA combined with vitrectomy and cataract surgery contributed to inhibit the postoperative inflammation in patients with VH due to PDR. The effect of IVTA in the reduction of diabetic macular oedema may be limited to the early stage after surgery. TRIAL REGISTRATION NUMBER: UMIN000020376, Post-results.
引用
- Takamura Y, Shimura M, Katome T, et al. Effect of intravitreal triamcinolone acetonide injection at the end of vitrectomy for vitreous haemorrhage related to proliferative diabetic retinopathy. Br J Ophthalmol. 2018. PMID: 29343528. doi:10.1136/bjophthalmol-2017-311377
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。